Yvette Leung

Yvette Leung is the VP, Head of Corporate Development at Dyno Therapeutics, an AI-powered gene therapy tech bio company backed by a16z. Yvette has a strong background in leading business development, strategy, alliance management, and external communications teams. Prior to this role, Yvette worked as the US Brand Lead, Hematology Marketing at Bristol Myers Squibb and Celgene, where Yvette successfully launched new therapies and spearheaded innovative marketing campaigns. Yvette also has experience as a Strategy Consultant in the biopharma industry and as a Senior Associate Consultant at L.E.K. Consulting. Yvette holds an MBA from The Wharton School and a B.A. in Chemical and Physical Biology from Harvard University.